These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8529255)

  • 21. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
    Palikhe A; Sinisalo J; Seppänen M; Haario H; Meri S; Valtonen V; Nieminen MS; Lokki ML
    Am J Cardiol; 2007 Apr; 99(7):890-5. PubMed ID: 17398178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prudent algorithm for hyperlipoproteinemia in renal transplant recipients.
    Nart A; Uslu A; Bozkaya G; Aykas A; Dogan M; Karaca B
    Transplant Proc; 2009 Mar; 41(2):751-5. PubMed ID: 19328972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002).
    Guttormsen BN; Stein JH; McBride PE; Cullen MW; Gangnon R; Keevil JG
    Am J Cardiol; 2007 Oct; 100(7):1130-3. PubMed ID: 17884376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of the short-term regular exercise-diet program on lipid profile in sedentary subjects].
    Yalin S; Gök H; Toksöz R
    Anadolu Kardiyol Derg; 2001 Sep; 1(3):179-8, AXV. PubMed ID: 12101821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for cardiovascular disease and diet of urban and rural dwellers in northern Nigeria.
    Glew RH; Conn CA; Vanderjagt TA; Calvin CD; Obadofin MO; Crossey M; Vanderjagt DJ
    J Health Popul Nutr; 2004 Dec; 22(4):357-69. PubMed ID: 15663169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
    Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum lipid profiles and homocysteine levels in adults with stroke or myocardial infarction in the town of Gombe in northern Nigeria.
    Glew RH; Okolie H; Crossey M; Suberu O; Trujillo M; Pereyra M; Vanderjagt DJ
    J Health Popul Nutr; 2004 Dec; 22(4):341-7. PubMed ID: 15663167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study.
    Leibovitz E; Harats D; Gavish D
    Isr Med Assoc J; 2002 Jun; 4(6):407-10. PubMed ID: 12073409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status and management of blood lipids in Greek adults and their relation to socio-demographic, lifestyle and dietary factors: the ATTICA Study. Blood lipids distribution in Greece.
    Panagiotakos DB; Pitsavos C; Chrysohoou C; Skoumas J; Stefanadis C
    Atherosclerosis; 2004 Apr; 173(2):353-61. PubMed ID: 15064113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of metabolic syndrome among young women with nonfatal myocardial infarction.
    Amowitz LL; Ridker PM; Rifai N; Loughrey CM; Komaroff AL
    J Womens Health (Larchmt); 2004 Mar; 13(2):165-75; discussion 175. PubMed ID: 15072730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association of serum C3 and essential hypertension].
    Bozzoli C; Muscari A; Puddu GM; Rovinetti C; Renzi C; Vallar G; Puddu P
    G Ital Cardiol; 1992 Dec; 22(12):1361-6. PubMed ID: 1294420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between serum C3 levels and traditional risk factors for myocardial infarction.
    Muscari A; Massarelli G; Bastagli L; Poggiopollini G; Tomassetti V; Volta U; Puddu GM; Puddu P
    Acta Cardiol; 1998; 53(6):345-54. PubMed ID: 10063429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.